BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 17724448)

  • 1. Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations.
    Prud'homme GJ
    Lab Invest; 2007 Nov; 87(11):1077-91. PubMed ID: 17724448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta: recent advances on its role in immune tolerance.
    Mantel PY; Schmidt-Weber CB
    Methods Mol Biol; 2011; 677():303-38. PubMed ID: 20941619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring anti-TGF-β therapies in cancer and fibrosis.
    Hawinkels LJ; Ten Dijke P
    Growth Factors; 2011 Aug; 29(4):140-52. PubMed ID: 21718111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis.
    Weeks BH; He W; Olson KL; Wang XJ
    Cancer Res; 2001 Oct; 61(20):7435-43. PubMed ID: 11606377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The soluble transforming growth factor-beta receptor: advantages and applications.
    Russo LM; Brown D; Lin HY
    Int J Biochem Cell Biol; 2009 Mar; 41(3):472-6. PubMed ID: 18339576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology.
    Morikawa M; Derynck R; Miyazono K
    Cold Spring Harb Perspect Biol; 2016 May; 8(5):. PubMed ID: 27141051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
    Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
    Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β1 - A truly transforming growth factor in fibrosis and immunity.
    Lodyga M; Hinz B
    Semin Cell Dev Biol; 2020 May; 101():123-139. PubMed ID: 31879265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent.
    Kaviratne M; Hesse M; Leusink M; Cheever AW; Davies SJ; McKerrow JH; Wakefield LM; Letterio JJ; Wynn TA
    J Immunol; 2004 Sep; 173(6):4020-9. PubMed ID: 15356151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases.
    Prud'homme GJ; Piccirillo CA
    J Autoimmun; 2000 Feb; 14(1):23-42. PubMed ID: 10648114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment.
    Chung JY; Chan MK; Li JS; Chan AS; Tang PC; Leung KT; To KF; Lan HY; Tang PM
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
    Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
    J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damage.
    Saxena V; Lienesch DW; Zhou M; Bommireddy R; Azhar M; Doetschman T; Singh RR
    J Immunol; 2008 Feb; 180(3):1903-12. PubMed ID: 18209088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune suppressive function of transforming growth factor-β (TGF-β) in human diseases.
    Sheng J; Chen W; Zhu HJ
    Growth Factors; 2015 Apr; 33(2):92-101. PubMed ID: 25714613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta).
    Chegini N
    Eur J Surg Suppl; 1997; (577):17-23. PubMed ID: 9076448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-β: A therapeutic target for cancer.
    Haque S; Morris JC
    Hum Vaccin Immunother; 2017 Aug; 13(8):1741-1750. PubMed ID: 28575585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-β-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis.
    Blyszczuk P; Müller-Edenborn B; Valenta T; Osto E; Stellato M; Behnke S; Glatz K; Basler K; Lüscher TF; Distler O; Eriksson U; Kania G
    Eur Heart J; 2017 May; 38(18):1413-1425. PubMed ID: 27099262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.